Migrasomes in kidney diseases: emerging molecular mechanisms, diagnostic value, and therapeutic prospects.
- 1Department of Nephropathy, The Second Hospital of Jilin University, Changchun 130041, Jilin Province, China.
Abstract
Migrasomes are migration-dependent extracellular organelles that form on retraction fibers of migrating cells. Although they can enter the extracellular space, their biogenesis and membrane organization are distinct from those of conventional extracellular vesicle subtypes. They are involved in intercellular signaling, clearance of cellular material, and maintenance of mitochondrial homeostasis. Emerging evidence suggests their involvement in the development of kidney diseases, such as podocyte injury, membranous nephropathy, diabetic kidney disease (DKD), and renal cell carcinoma (RCC). Podocyte-derived migrasomes in urine have shown potential as non-invasive biomarkers for early detection of kidney injury, with levels correlating with PLA2R antigen expression in membranous nephropathy. In DKD, migrasomes may help mitigate oxidative stress by removing damaged mitochondria. In clear cell renal cell carcinoma, they appear to influence the tumor microenvironment, affecting disease progression and prognosis. However, research on migrasomes in kidney diseases is still in its early stages. Challenges, including an incomplete understanding of their mechanisms and a lack of standardized detection methods, limit clinical application. This review outlines recent advances in understanding migrasomes and explores their potential for early diagnosis, disease monitoring, and prognosis evaluation in kidney diseases, while discussing existing barriers to guide future research efforts.
Related
- Extracellular Vesicles in Molecular Crosstalk and Disease Pathogenesis: A Comprehensive Review on Mechanisms and Therapeutic Prospects
- The Role of Neutrophil Extracellular Traps (NETosis) in Systemic Lupus Erythematosus: Molecular Mechanisms, Pathogenic Roles, Diagnostic Biomarkers, and Emerging Therapeutic Strategies
- Research progress of extracellular vesicles in PMOS: molecular mechanisms, diagnostic value, and therapeutic strategies
- Metal Hypersensitivity in Total Joint Arthroplasty: Molecular Immunopathogenesis, Diagnostic Controversies, and Prospects for Precision Medicine
- Cuproptosis: New Mechanisms Linking Endothelial Dysfunction to Neurodegenerative Diseases and Therapeutic Prospects
BibTeX
@article{qin2026migrasomes,
title = {{Migrasomes in kidney diseases: emerging molecular mechanisms, diagnostic value, and therapeutic prospects.}},
author = {Wei Qin and Bing Li and Yixian Zhang and Ping Nie},
journal = {Biochemical Society transactions},
year = {2026},
month = oct,
doi = {10.1042/bst20260952},
url = {https://europepmc.org/article/MED/42922407},
note = {CC BY},
}
RIS
TY - JOUR
TI - Migrasomes in kidney diseases: emerging molecular mechanisms, diagnostic value, and therapeutic prospects.
AU - Wei Qin
AU - Bing Li
AU - Yixian Zhang
AU - Ping Nie
PY - 2026
DA - 2026/10/01
JO - Biochemical Society transactions
DO - 10.1042/bst20260952
UR - https://europepmc.org/article/MED/42922407
AB - Migrasomes are migration-dependent extracellular organelles that form on retraction fibers of migrating cells. Although they can enter the extracellular space, their biogenesis and membrane organization are distinct from those of conventional extracellular vesicle subtypes. They are involved in intercellular signaling, clearance of cellular material, and maintenance of mitochondrial homeostasis. Emerging evidence suggests their involvement in the development of kidney diseases, such as podocyte injury, membranous nephropathy, diabetic kidney disease (DKD), and renal cell carcinoma (RCC). Podocyte-derived migrasomes in urine have shown potential as non-invasive biomarkers for early detection of kidney injury, with levels correlating with PLA2R antigen expression in membranous nephropathy. In DKD, migrasomes may help mitigate oxidative stress by removing damaged mitochondria. In clear cell renal cell carcinoma, they appear to influence the tumor microenvironment, affecting disease progression and prognosis. However, research on migrasomes in kidney diseases is still in its early stages. Challenges, including an incomplete understanding of their mechanisms and a lack of standardized detection methods, limit clinical application. This review outlines recent advances in understanding migrasomes and explores their potential for early diagnosis, disease monitoring, and prognosis evaluation in kidney diseases, while discussing existing barriers to guide future research efforts.
SN - 0300-5127
SN - 1470-8752
ER -